StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a report issued on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Shares of NASDAQ VBLT opened at $0.16 on Monday. Vascular Biogenics has a fifty-two week low of $0.10 and a fifty-two week […]
StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a report published on Monday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Down 8.8 % Shares of VBLT opened at $0.16 on Monday. The company has a market cap of $12.11 million, a PE ratio […]
StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note issued to investors on Sunday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ VBLT opened at $0.16 on Friday. The business has a 50 day simple moving average of $0.20 and […]
StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note published on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance NASDAQ VBLT opened at $0.16 on Friday. Vascular Biogenics has a 1 year low of $0.10 and a 1 year […]
StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research report released on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance VBLT stock opened at $0.25 on Wednesday. The business has a 50-day moving average price of $0.24 and a 200 day […]